@article{oai:tohoku-mpu.repo.nii.ac.jp:00000742,
 author = {宇野, 尭 and Uno, Takashi and 矢花, 郁子 and Yabana, Ikuko and 森, 建文 and Mori, Takefumi and 内海, 由也 and Utumi, Yuya and 伊藤, 修 and Ito, Osamu and 藤村, 茂 and Fujimura, Shigeru and 薄井, 健介 and Usui, Kensuke and 岡田, 浩司 and Okada, Kouji and 渡辺, 善照 and Watanabe, Yoshiteru},
 issue = {64},
 journal = {東北医科薬科大学研究誌, Journal of Tohoku Medical and Pharmaceutical University},
 month = {Dec},
 note = {A 73 years old woman in her with end-stage renal disease（ESRD）had fallen from bed and damaged the cervical vertebrae at home, and the posterior cervical fusion surgery was performed at previous hospital. She was hospitalized to the General Medicine and Rehabilitation ward, and peritoneal dialysis therapy was performed by the division of Nephology and Endocrinology. Because of the difficulty in self assessment of peritoneal dialysis and loss of residual renal function, she was shifted to hemodialysis therapy. Since phosphorus binders were kept receiving after hemodialysis, lowered serum phosphate level was observed. Serum phosphate level was normalized by appropriate dosaging of phosphate binders by pharmacist s consultation. It is necessary to reconsider the dosage and compliance of phosphate binders, phosphorus intake residual renal function, and amount of phosphorus removal by dialysis therapy. In this regard, there is assessment role in the pharmacist s consultation for assessment of mineral and bone disorder together with the medication guidance and side effect evaluation.},
 pages = {115--121},
 title = {薬剤師による総合的な骨・ミネラル代謝異常の管理により高リン血症治療薬の副作用が回避できた一例},
 year = {2017},
 yomi = {ウノ, タカシ and ヤバナ, イクコ and モリ, タケフミ and ウツミ, ユウヤ and イトウ, オサム and フジムラ, シゲル and ウスイ, ケンスケ and オカダ, コウジ and ワタナベ, ヨシテル}
}